Progressive depletion of peripheral B lymphocytes in 4-1BB (CD137) ligand/I-Eα-transgenic mice

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2671-2676

  Zhu, G ^a   Flies, D B ^a   Tamada, K ^a   Sun, Y ^a   Rodriguez, M ^a   Fu, Y X ^a   Chen, L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD137 ANTIGEN; CD137 LIGAND; COMPLEMENTARY DNA; IMMUNOGLOBULIN G; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SPLENOMEGALY; T LYMPHOCYTE;

EID: 0035451675     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2671     Document Type: Article

References (25)

1. Modulation of the immune response through 4-1BB
2. Role of 4-1BB in immune responses
3. T cell co-stimulatory molecules other than CD28
4. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB
5. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand
6. ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages
7. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
8. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
9. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy
10. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal
11. Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells
12. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus
13. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination
14. 4-1 BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
15. ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival
16. CD137 (ILA/4-IBB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling
17. CD137 induces proliferation and endomitosis in monocytes
18. 4-IBB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells
19. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice
20. Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16
21. B-cell control region at the 5′ end of a major histocompatibility complex class II gene: Sequences and factors
22. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
23. CD137-induced apoptosis is independent of CD95
24. CDI37 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes
25. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice